The positive expression rate of TβRII and Smad4 in the poorly-differentiated lung carcinoma group was significantly lower when compared with the well- and moderately-differentiated lung carcinoma groups, exhibiting a statistically significant difference (P<0.05). This evidence concerns the gene TGFBR2 and lung carcinoma.